跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-HYDROCHLOROTHIAZIDE TABLET 50 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-HYDROCHLOROTHIAZIDE TABLET 50 MG
Approved
THERAPEUTIC
APO-HYDROCHLOROTHIAZIDE TABLET 50 MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 5, 1989
Approval ID
55523662a98e59b0
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
55523662a98e59b0
Drug Name
APO-HYDROCHLOROTHIAZIDE TABLET 50 MG
Product Name
APO-HYDROCHLOROTHIAZIDE TABLET 50 MG
Approval Number
SIN03675P
Approval Date
1989-08-05
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C03AA03
Atc Item Name
hydrochlorothiazide
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
HYDROCHLOROTHIAZIDE
50 mg
HYDROCHLOROTHIAZIDE
50 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 5, 1989
Approval ID
55523662a98e59b0
Type
Therapeutic
Back to HSA Approvals